Cargando…
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in Wuhan, China and spread rapidly. Recent studies have found that ⁓ 15.7% of patients develop severe pneumonia, and cytokine storm is an important factor leading to rapid disease progression. Currently, there are no specif...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183818/ https://www.ncbi.nlm.nih.gov/pubmed/32337664 http://dx.doi.org/10.1007/s40261-020-00917-3 |